Difficulty: Medium
Average Score: 93%
Practice
A 42-year-old woman presents to the emergency department with vaginal bleeding for the past 2 days. Her last menstrual period was 1 week ago and has had regular cycles. She has a history of a hydatidiform mole 8 years ago. A β-hCG is 20,000. The diagnosis of choriocarcinoma is made and she is started on methotrexate. What is the mechanism of action of methotrexate?
Correct answer
B
Rationale
The correct answer is B) Inhibits dihydrofolate reductase.
Methotrexate is a folate analog that competitively inhibits dihydrofolate reductase, an enzyme crucial for the synthesis of tetrahydrofolate, a key molecule in the synthesis of purines and pyrimidines. By inhibiting this enzyme, methotrexate disrupts the production of DNA and RNA, leading to inhibition of cell proliferation, particularly in rapidly dividing cells like cancer cells.
Option A) Alkylates DNA is incorrect because methotrexate does not directly alkylate DNA.
Option C) Inhibition of DNA polymerase is incorrect because methotrexate does not directly inhibit DNA polymerase.
Option D) Inhibits thymidylate synthase is incorrect because methotrexate does not directly inhibit thymidylate synthase, which is involved in the synthesis of thymidine.
Understanding the mechanism of action of methotrexate is crucial in the context of chemotherapy for various malignancies, including choriocarcinoma. By inhibiting dihydrofolate reductase, methotrexate disrupts cancer cell growth and division, leading to its therapeutic effect. This knowledge is essential for healthcare professionals to effectively manage patients undergoing chemotherapy and to minimize adverse effects.
Methotrexate is a folate analog that competitively inhibits dihydrofolate reductase, an enzyme crucial for the synthesis of tetrahydrofolate, a key molecule in the synthesis of purines and pyrimidines. By inhibiting this enzyme, methotrexate disrupts the production of DNA and RNA, leading to inhibition of cell proliferation, particularly in rapidly dividing cells like cancer cells.
Option A) Alkylates DNA is incorrect because methotrexate does not directly alkylate DNA.
Option C) Inhibition of DNA polymerase is incorrect because methotrexate does not directly inhibit DNA polymerase.
Option D) Inhibits thymidylate synthase is incorrect because methotrexate does not directly inhibit thymidylate synthase, which is involved in the synthesis of thymidine.
Understanding the mechanism of action of methotrexate is crucial in the context of chemotherapy for various malignancies, including choriocarcinoma. By inhibiting dihydrofolate reductase, methotrexate disrupts cancer cell growth and division, leading to its therapeutic effect. This knowledge is essential for healthcare professionals to effectively manage patients undergoing chemotherapy and to minimize adverse effects.